Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
-
Market Cap
1.17B
Enterprise Value
-
Income
-
Sales
-
Book/sh
-
Cash/sh
-
Employees
-
IPO
Apr 23, 1987
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
-
Current Ratio
-
Debt/Eq
-
LT Debt/Eq
-
Option/Short
No / Yes
EPS (ttm)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -
Sales past 3/5Y
- -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
-
Insider Trans
-
Inst Own
23.65%
Inst Trans
-
ROA
-
ROE
-
ROIC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
2.78%
SMA50
-5.05%
SMA200
1.03%
Trades
Shs Outstand
57.19M
Shs Float
57.19M
52W High
24.85 -17.63%
52W Low
17.14 19.43%
Volatility
2.94% 3.05%
ATR (14)
0.58
RSI (14)
51.69
Beta
0.76
Rel Volume
0.51
Avg Volume
193.99K
Volume
79,579
Perf Week
6.06%
Perf Month
-5.23%
Perf Quarter
-4.79%
Perf Half Y
5.41%
Perf YTD
8.08%
Perf Year
8.88%
Perf 3Y
38.31%
Perf 5Y
-21.03%
Perf 10Y
-6.76%
Recom
-
Target Price
-
Prev Close
20.29
Price
20.47
Change %
0.89%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goodson Alan RDirectorOct 06 '26Sale19.322424,6750Oct 07 12:57 PM
Mahai Chris LaVictoireDirectorJul 16 '26Buy20.9650110,501501Jul 20 02:34 PM
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Ph.D.Dr. Daniel R. Omstead M.S
M.D.Dr. Jason C. Akus M.B.A.
Senior Vice President of Research and Portfolio ManagerMr. Christopher F. Brinzey MBA
Senior Vice President of Research and Portfolio ManagerDr. Frank T. Gentile Ph.D.